Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Page 2

Schroders shifts Carrick stake at discount
Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.
Paragon passes acquisition exam
University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.
Oxford Endovascular enters series A stage
University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.
Vaccitech shoots for US IPO
Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.
Daily deal net: April 9, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus Therapeutics executes $100m series B
RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.
Metagenomi magnifies series A to $75m
UC Berkeley's DNA-editing technology spinout has raised $10m from RA Capital in addition to the $65m it pocketed in November.
Icosavax racks up $100m
RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.
JGC invests $40m in NuScale Power
JGC Holdings bacame the latest investor in the modular nuclear reactor technology developer, which emerged out of Oregon State University.
Guardian Agriculture takes off with series A
The drone-based crop analysis system developer secured $10.5m in a round led by Leaps by Bayer that also featured MIT-linked E14 Fund.

test reg